Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Basal Like”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07665684
What this trial is testing

Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer

Who this might be right for
Pancreas Ductal AdenocarcinomaPancreas Cancer, MetastaticPancreatic Adenocarcinoma Metastatic+2 more
University Health Network, Toronto 67
Early research (Phase 1)Study completedNCT01650506
What this trial is testing

Study of Erlotinib and Metformin in Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Columbia University 8
Large-scale testing (Phase 3)Study completedNCT02229227
What this trial is testing

Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 814
Large-scale testing (Phase 3)Study completedNCT01881230
What this trial is testing

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

Who this might be right for
Breast TumorBreast CancerCancer of the Breast+8 more
Celgene 191
Not applicableStudy completedNCT02699190
What this trial is testing

LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies

Who this might be right for
LeukodystrophyWhite Matter Disease4H Syndrome+61 more
Children's Hospital of Philadelphia 236
Large-scale testing (Phase 3)Not Yet RecruitingNCT07669610
What this trial is testing

An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Bevacizumab in First to Third Line BLIS Subtype TNBC

Who this might be right for
Breast CancerTriple Negative Breast Cancer (TNBC)
Fudan University 140
Not applicableLooking for participantsNCT03047369
What this trial is testing

The Myelin Disorders Biorepository Project

Who this might be right for
LeukodystrophyWhite Matter DiseaseLeukoencephalopathies+63 more
Children's Hospital of Philadelphia 12,000
Testing effectiveness (Phase 2)Looking for participantsNCT06483555
What this trial is testing

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel

Who this might be right for
Pancreatic AdenocarcinomaMetastatic Pancreatic CancerBasal Cell Neoplasm
UNC Lineberger Comprehensive Cancer Center 104
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Early research (Phase 1)Study completedNCT05638620
What this trial is testing

Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID

Who this might be right for
Post Acute COVID-19 SyndromeLong COVIDLong Covid19+12 more
Jonathann Kuo, MD 20
Post-approval studies (Phase 4)Study completedNCT05218915
What this trial is testing

Basal Plus GLP1-ra on Glycemic Variability in CKD

Who this might be right for
Diabetes MellitusDiabetic Kidney Disease
Elaine Chow 95